If you want to shop for bargains in the U.S. stock market now that many names are on sale, who better to turn to for guidance than a value manager with a long history of beating a benchmark index.

A single lifileucel treatment is expected to cost $515,000. Buying stocks under $10 isn’t for the faint of heart. Many of these stocks are extremely volatile and high-risk speculative investments.

Kiplinger's annual investing outlook, which includes the best stocks to buy, has been a feature for our readers since 2012. As executive editor for Kiplinger's Personal Finance Magazine ...

The Spanish stock market regulator said it will wait for the competition authority's review of Banco Bilbao Vizcaya Argentaria's bid for smaller peer Banco de Sabadell before deciding whether to ...

Calculate the capital gains taxes you may need to pay or the tax advantages that may help if you sell stocks at a loss. A capital gain is any profit from the sale of a stock, and it has unique tax ...

Brett uses “second-level thinking” to find dividend stocks to buy ... alternatives”—Wall Street code for “exploring a sale.” Griffon has become cheap, however, courtesy of a nearly ...

The Green Bay Packers’ stock sale begins Tuesday, Nov. 16 at $300 per share. This is the sixth time the NFL team is selling its stock. The Packers is offering 300,000 shares which will continue ...

ResMed Inc. is preparing for a significant sale of its common stock, with Michael Farrell, a company officer and director, planning to sell 14,683 shares. The sale, which is planned for November 7 ...

If you buy back the stock less than 30 days after you sold it, the sale will fall under the “wash rule” and can’t be claimed for tax purposes. Editorial Disclaimer: Opinions expressed here ...

Boeing (BA) needs a lot of cash, quickly, as it figures out how much longer it can hold out without making a deal to bring its striking machinists back to work. Wall Street decided to give the ...

In addition, Salesforce supported its share price by repurchasing nearly $2 billion in stock in the third quarter. While Salesforce’s spectacular growth finally seems to be slowing, its pivot to ...